ストックスクリーナーアプリを入手
4.42
0.67%
-0.03
前日終値:
$4.45
開ける：
$4.4015
24時間の取引高:
64,195
Relative Volume:
0.71
時価総額：
$84.16M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-1.34%
1か月 パフォーマンス:
+4.99%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$4.30
$4.80
1週間の範囲:
$4.12
$4.80
52週間の値動き範囲:
$3.63
$5.50
Basel Medical Group Ltd Stock (BMGL) Company Profile
BMGL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BMGL
Basel Medical Group Ltd
|
4.42 | 84.16M | 0 | 0 | 0 | 0.00 |
|
HCA
Hca Healthcare Inc
|
317.61 | 83.86B | 70.60B | 5.76B | 5.64B | 21.97 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.52 | 14.48B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
DVA
Davita Inc
|
133.50 | 11.70B | 12.67B | 827.68M | 1.42B | 9.27 |
|
UHS
Universal Health Services Inc
|
157.05 | 11.66B | 15.42B | 1.03B | 956.84M | 15.02 |
|
THC
Tenet Healthcare Corp
|
110.41 | 10.88B | 20.97B | 3.13B | 2.39B | 31.21 |
Basel Medical Group Ltd (BMGL) 最新ニュース
Basel Medical Group announces leadership shake-up - Investing.com Australia
Basel Medical Group announces leadership shake-up By Investing.com - Investing.com India
Basel Medical Group Announces Leadership Changes in April 2025 - TipRanks
Basel Medical Group Ltd -Resignation Of Raymond Cheung As Chief Executive Officer - marketscreener.com
WORK Medical Technology Group receives Nasdaq notification - Medical Buyer
Basel Medical Group acquires Bethesda Medical - Medical Buyer
SEA Digest: Basel to buy SG's Bethesda Medical; Indonesia's Surge bags NTT East investment - DealStreetAsia
Bethesda Medical acquired by Basel Medical - Crunchbase
Basel Medical to acquire Bethesda Medical, terms undisclosed - TipRanks
Basel Medical Group Expands with Acquisition of Bethesda Medical - TipRanks
Basel Medical Group to Acquire Bethesda Medical in Southeast Asia Expansion Push - marketscreener.com
Basel Medical to buy Singapore-based Bethesda Medical - Seeking Alpha
Basel Medical To Acquire Singapore's Bethesda Medical For Undisclosed Terms - Nasdaq
Basel Medical Group Signs Agreement to Acquire Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia - The Manila Times
Basel Medical Group Signs Agreement to Acquire Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia - GlobeNewswire Inc.
Pre-market Movers: VERO, WORX, QLGN, VINC... - RTTNews
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Pre-market Movers: VERO, WORX, GFR, ALTG, QLGN… - RTTNews
Venus Shines, VRDN On Track For BLA Submission, AVDL On Watch - RTTNews
Basel Medical Group Appoints Founder Raymond Fung to Board - TipRanks
OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer - PR Newswire
Oscar-winning Palestinian director ‘attacked by Israeli settlers and detained’ - North Wales Chronicle
Palestinian Director of 'No Other Land' Attacked by Settler Mob, Arrested by Soldiers, Israeli Co-director Says - Haaretz
Basel Medical Group Completes Overallotment Option Exercise in IPO - TipRanks
Basel Medical Group Ltd Announces Exercise of Overallotment Option - The Manila Times
Orchid Island Capital Announces March 2025 Monthly Dividend and February 28, 2025 RMBS Portfolio Characteristics - The Manila Times
Basel Medical Group Ltd Completes Full Exercise of Overallotment Option in IPO, Raising Additional $1.32 Million - Nasdaq
Novartis is watching US reciprocal tariff policy 'very carefully', CEO says - Reuters
Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates - TradingView
Roche secures Zealand obesity drug candidate for up to $5.3 billion - Reuters
Med-tech sector starts strong, with $6.28B in 2025 financings - BioWorld MedTech
Kestra Medical stock surges on public debut (KMTS:NASDAQ) - Seeking Alpha
Basel Medical prices $8.8M IPO - BioWorld Online
Basel Medical Group Ltd Completes $8.82 Million IPO - TipRanks
Mahindra Launches two Electric Origin SUVs, the BE 6 & the XEV 9e for India, Available with Monroe Intelligent Suspension Technology - The Manila Times
Basel Medical Group Ltd Closes $8.82 Million Initial Public Offering on Nasdaq - Nasdaq
Phase III study shows Xolair may be more effective with fewer side effects than oral immunotherapy for the treatment of food allergies - Yahoo Finance
U.S. IPO Weekly Recap: Small Asia-Based Names List, As TV Adtech MNTN And Others Join The Pipeline - Seeking Alpha
Basel Medical Group Ltd Launches $8.82 Million IPO on Nasdaq - TipRanks
Basel Medical Group stock edges up 4% following U.S. IPO - MSN
Basel Medical Group Prices IPO At $4.00 Per Share, Raising $8.82Mln; Stock Down - Nasdaq
Basel Medical Group Prices US $8,820,000 Initial Public Offering - TradingView
Basel Medical prices IPO of over 2 million shares at $4.00 per share - Investing.com India
Why Basel Medical Group Ltd (NASDAQ:BMGL) Looks Like A Quality Company - Yahoo Finance
Basel Medical Prices IPO at $4.00-$5.00 Per Share (BMGL) - Defense World
Validating candidate endpoints for intermediate age-related macular degeneration trials in a multi-centre setting—lessons from the MACUSTAR study | Eye - Nature
Roche Group's total sales 2006-2024 - Statista
Opening Day: LNG player Venture Global opens below reduced IPO price - TipRanks
Opening Day: Oilfield services provider Flowco jumps in market debut - Yahoo Finance
Switzerland’s Basel Region Crowned ‘Europe’s Top Destination to Launch a Drug Device Company’, According to Pharmapack Report - Pharmafile
Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers - Fierce Biotech
Basel Medical Group Ltd (BMGL) 財務データ
Basel Medical Group Ltd (BMGL) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.08%
2.40%
大文字化:
|
ボリューム (24 時間):